Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms

World J Gastrointest Surg. 2022 Apr 27;14(4):276-285. doi: 10.4240/wjgs.v14.i4.276.

Abstract

Neuroendocrine neoplasms (NENs) of the gastroenteropancreatic system are rare and heterogeneous tumours, yet with increasing prevalence. The most frequent primary sites are the small intestine, rectum, pancreas, and stomach. For a localized disease, surgical resection with local lymph nodes is usually curative with good overall and disease free survival. More complex situation is the treatment of locally advanced lesions, liver metastases, and, surprisingly, small asymptomatic tumours of the rectum and pancreas. In this review, we focus on the current role of surgical management of gastroenteropancreatic NENs. We present surgical approach for the most frequent primary sites. We highlight the role of endoscopic surgery and the watch-and-wait strategy for selected cases. As liver metastases pose an important clinical challenge, we present current indications and contraindications for liver resection and a role of liver transplantation for metastatic NENs.

Keywords: Gastroenteropancreatic neuroendocrine neoplasms; Liver metastases; Liver transplantation; Management; Surgery; Treatment.

Publication types

  • Review